Geoffrey Purtill - 24 Apr 2023 Form 4 Insider Report for INVACARE CORP

Role: President and CEO
Signature: /s/ Geoffrey Purtill, by Kristofer K. Spreen, his attorney-in-fact, pursuant to Power of Attorney dated November 24, 2021, on file with the Commission
Issuer symbol: N/A
Transactions as of: 24 Apr 2023
Net transactions value: $0
Form type: 4
Filing time: 24 Apr 2023, 17:45:36 UTC
Previous filing: 28 Feb 2023
Next filing: 15 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IVC	Common Shares	Disposed to Issuer	$0	-128,293	-82%	$0.000000	27,793	24 Apr 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	IVC	Employee Stock Option (Right to Buy)						17,611	24 Apr 2023	Common Shares	17,611		Direct	F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person forfeited 128,293 restricted stock units back to the issuer.
F2	No transaction is being reported on this line. Reported on previously filed Form 3.
F3	The reporting person holds previously reported options to buy 17,611 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2013 Equity Compensation Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted on March 16, 2017, at an exercise price of $12.15 per share, will expire on March 16, 2027, and became exercisable on December 31, 2019.
F4	The current balance reflects the expiration of 5,000 options on March 18, 2023.